The Biomarkers of Oral Cancer

Dear Colleagues,

We are pleased to invite you to contribute to this Special Issue on "The Biomarkers of Oral Cancer." Oral cancer remains a significant global health challenge, with approximately 377,000 new cases diagnosed annually worldwide. Despite advances in treatment modalities, the 5-year survival rate remains around 50%, largely due to late-stage diagnosis. The identification and validation of reliable biomarkers for early detection, prognosis, and therapeutic monitoring represent a critical frontier in improving patient outcomes and personalizing treatment strategies.

This Special Issue aims to compile cutting-edge research on molecular, genetic, and protein biomarkers that can revolutionize oral cancer management. We seek to present comprehensive insights into novel biomarker discovery, validation studies, and their clinical translation, aligning with Cancers' scope of advancing cancer research through molecular and clinical investigations.

In this Special Issue, original research articles and reviews are welcome. Research areas may include (but are not limited to) the following:

• Salivary and circulating biomarkers for early detection.
• Genetic and epigenetic markers for risk assessment.
• Prognostic biomarkers for treatment stratification.
• Liquid biopsy approaches in oral cancer.
• Multi-omics integration for biomarker discovery.
• Clinical validation and implementation studies.

I look forward to receiving your contributions.

Dr. Yasumasa Kakei
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.